Figure 1From: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequencesA schematic illustration depicting the construction of the double promoter H19-DTA-P4-DTA expression vector: The coding sequence of each DTA is under the transcriptional control of both H19 and IGF2-P4 promoter sequences, respectively, Kana (R) - kanamycine resistance gene.Back to article page